Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2024 ∙ Maamor, N. H. Muhamad, N. A. Mohd Dali, N. S. Leman, F. N. Rosli, I. A. Tengku Bahrudin Shah, T. P. N. Jamalluddin, N. H. Misnan, N. S. Mohamad, Z. A. Bakon, S. K. Mutalip, M. H. A. Hassan, M. R. A. Lai, N. M.

Prevalence of caregiver hesitancy for vaccinations in children and its associated factors: A systematic review and meta-analysis

  • Parents/caregivers
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Tavares, L. O. M. Silva, M. A. Oliveira, B. R. Amaral, G. G. Guimaraes, E. A. A. Couto, R. O. Oliveira, V. C.

Prevalence of errors causing events allegedly attributable to vaccination/immunization: systematic review and meta-analysis

  • All age groups
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Leon-Figueroa, D. A. Barboza, J. J. Valladares-Garrido, M. J. Sah, R. Rodriguez-Morales, A. J.

Prevalence of intentions to receive monkeypox vaccine. A systematic review and meta-analysis

  • All age groups
  • Mpox
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Al Shahrani, A. Alhumaidan, N. Alzelfawi, L. AlDosari, L. Alhindawi, Z. Alotaibi, N. Aljohani, R.

Prevalence of menstrual alterations following COVID-19 vaccination: systematic review & meta-analysis

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Chen, Y. J. Lin, Y. C. Wu, M. T. Kuo, J. Y. Wang, C. H.

Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis

  • All age groups
  • Hepatitis B
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Tsang, T. K. Sullivan, S. G. Huang, X. Wang, C. Wang, Y. Nealon, J. Yang, B. Ainslie, K. E. C. Cowling, B. J.

Prior infections and effectiveness of SARS-CoV-2 vaccine in test-negative studies: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Duradoni, M. Tosti, A. E. Colombini, G. Masti, F. Licata, A. L. Zanobini, P. Materassi, L. Guazzini, A.

Promoters and Barriers of Vaccine Hesitancy

  • All age groups
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Properzi, S. Sepioni, M. S. Carestia, R. Cervelli, G. de Waure, C.

Promoting Vaccinations in Pregnancy: Results of a Systematic Literature Review of Italian Initiatives

  • Europe
  • Italy
  • Pregnant women
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Ferdinands, J. M. Blanton, L. H. Alyanak, E. Chung, J. R. Trujillo, L. Taliano, J. Morgan, R. L. Fry, A. M. Grohskopf, L. A.

Protection against influenza hospitalizations from enhanced influenza vaccines among older adults: A systematic review and network meta-analysis

  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2024 ∙ Abuelazm, M. T. Elzeftawy, M. A. Kamal, M. A. Badr, H. Gamal, M. Aboulgheit, M. Abdelazeem, B. Abd-elsalam, S. Abouzid, M.

Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials

  • All age groups
  • Malaria
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...